Next Article in Journal
Pharmacological Effects of Two Novel Bombesin-Like Peptides from the Skin Secretions of Chinese Piebald Odorous Frog (Odorrana schmackeri) and European Edible Frog (Pelophylax kl. esculentus) on Smooth Muscle
Next Article in Special Issue
Cadmium Disrupts Subcellular Organelles, Including Chloroplasts, Resulting in Melatonin Induction in Plants
Previous Article in Journal
Ureidopyrazine Derivatives: Synthesis and Biological Evaluation as Anti-Infectives and Abiotic Elicitors
Previous Article in Special Issue
Melatonin Improves the Photosynthetic Carbon Assimilation and Antioxidant Capacity in Wheat Exposed to Nano-ZnO Stress
Article Menu
Issue 10 (October) cover image

Export Article

Molecules 2017, 22(10), 1793; doi:10.3390/molecules22101793

Article
The Regulatory Mechanism of MLT/MT1 Signaling on the Growth of Antler Mesenchymal Cells
Feifei Yang 1,2, Changjiu He 1, Xuyang Sun 1, Jing Wang 3, Can Luo 1, Guoshi Liu 3Orcid, Liguo Yang 1, Jiajun Xiong 1,* and Lijun Huo 1,*
1
Key Lab of Agricultural Animal Genetics, Breeding and Reproduction of Ministry of Education, College of Animal Science and Technology, Huazhong Agricultural University, Wuhan 430070, China
2
Department of Animal Husbandry and Veterinary, Wuhan Agricultural School, Wuhan 430043, China
3
National Engineering Laboratory for Animal Breeding, Key Laboratory of Animal Genetics and Breeding of the Ministry of Agriculture, Beijing Key Laboratory for Animal Genetic Improvement, College of Animal Science and Technology, China Agricultural University, Beijing 100193, China
*
Correspondence: Tel.: +86-027-8728-0020 (J.X.); +86-027-8728-0022 (L.H.)
Received: 27 September 2017 / Accepted: 19 October 2017 / Published: 23 October 2017

Abstract

:
Melatonin (MLT) plays an important role in regulating the physiological cycle of seasonal breeding animals. Melatonin receptor I (MT1) is effectively expressed in the cambium layer of deer antler. However, the function and metabolic mechanism of MLT/MT1 signaling in the mesenchymal cells of sika deer remain to be further elucidated. In this work, we detected the effects of MLT/MT1 signaling on mesenchymal cells proliferation and the interaction between MLT/MT1 and IGF1/IGF1-R signaling. The results show that (1) deer antler mesenchymal cells actually express MT1; (2) exogenous melatonin significantly promotes mesenchymal cells proliferation, while MT1 knock-down significantly impairs the positive effects of melatonin; and (3) melatonin significantly enhanced IGF1/IGF1-R signaling, as both the expression of IGF1 and IGF-1R increased, while MT1 knock-down significantly decreased IGF1-R expression and IGF1 synthesis. In summary, these data verified that MLT/MT1 signaling plays a crucial role in antler mesenchymal proliferation, which may be mediated by IGF1/IGF1-R.
Keywords:
sika deer; melatonin; MT1; mesenchymal cells; IGF1

1. Introduction

Antler is an ideal model for organ regeneration research, as it can regenerate periodically after amputation [1,2,3]. During deer antler growth, the periosteum is transformed into mesenchymal tissue, and mesenchymal cells develop into cartilage cells. Mesenchymal proliferation determines the speed of antler growth [4,5]. Mesenchymal cells are considered to be a major cell source of velvet growth, as it can differentiate into fibroblasts, chondrocytes, and osteocytes during velvet growth [6,7]. It was verified that growth factors play a major role in antler development. Insulin-like growth factor I (IGF1) is the crucial growth factor that stimulates antler growth. During velvet regeneration and development, plasma levels of IGF1 are significantly elevated during the velvet antler growth phase, relative to the other phases of pedicle, as well as first antler development, and a strong positive correlation exists between antler growth rate and circulating concentrations of IGF1 [8]. The effects of IGF1 on the growth of the fibroblast and cartilage zones were investigated; IGF1 was found to be mitogenic for cells originating from the perichondrium, mesenchyme, and cartilage zone of antler [9,10]. The localization of IGF1 in chondrocytes and osteoblasts also suggests that IGF1 may play an important role in cartilage and bone formation [11,12].
Melatonin (MLT), a multi-function hormone, plays an important role in the regulation of redox equilibrium, circadian rhythm, sleep, metabolic activities, mood disorders, as well as immunity [13,14,15,16,17,18,19]. It was well-documented that melatonin significantly suppresses experimental carcinogenesis in vivo [20]. Studies have shown that melatonin promotes cell survival and inhibits apoptosis, mainly through its antioxidizing action [21]. The mitochondria are the main source of intracellular free-radicals, and a recent study showed that the mitochondria possess the ability to synthesize melatonin and it was further verified that de novo melatonin production in the mitochondria provides one-site protection, which contributes to mitochondria function and less free-radical production [22]. In addition to its direct antioxidation, the receptor pathway of melatonin also plays an important role in cell proliferation and differentiation. MT1 and MT2, the trans-membrane receptors of melatonin, were studied deeply over the last decade. Recently, it was verified that melatonin promotes granulosa cell luteinization and embryo implantation, which are mediated by MT1 and MT2, respectively [23,24]. Moreover, agomelatine, the newer antidepressant which, acting synergistically on MT1 and MT2 receptors, displays robust anxiolytic-like actions [25,26]. Studies have shown that melatonin promotes antler growth. Oral administration of melatonin shortens the antler cycle of white-tailed deer; the number of cycles per year increased from one to two. Melatonin treatment also induced stag estrus performance and then stimulated antler growth [27,28,29]. Suttie et al. reported that IGF1 levels during the antler cycle are affected by melatonin treatment, and melatonin implantation advanced the seasonal patterns of increases and decreases of plasma IGF1 and also of weight gain and loss. The cessation of melatonin treatment in February produced early antler castings, as well as a second (out-of-season) antler, and increased IGF1 [30]. Our previous works have also verified that antler yield was affected by base mutation of IGF and MT1 receptors [31,32]. To sum up, melatonin participates in the regulation of antler regeneration; however, the mechanisms have not yet been clearly investigated.
In the current study, we conducted a series of experiments to determine whether MLT/MT1 signaling influences the growth of antler mesenchymal cells. Initially, we examined the distribution of melatonin receptors, MT1, and evaluated the effects of exogenous melatonin on cell proliferation. Thereafter, RNAi was adopted to decrease MT1 levels in order to inhibit MLT/MT1 signaling, and cell proliferation as well as cell cycle-related genes (PCNA, CyclinD2, p21, p27) were detected. Finally, the effects of MLT/MT1 signaling on IGF1/IGF-1R signaling were also explored.

2. Results

2.1. Effect of Melatonin on Cell Proliferation

Figure 1A shows an image acquired using toluidine blue-staining, which verified that the target cell was a mesenchymal cell. Culture medium supplemented with melatonin exhibited a beneficial effect on cell proliferation; the results showed that the cell proliferation rate was significantly higher in the melatonin group (800, 2000 pg/mL) after 48–72 h culture (p < 0.05), and the proliferation rate was highest in the 800 ng/mL group after a 72-h culture (0.55 ± 0.06 vs. 0.38 ± 0.03, p < 0.01) (Figure 1B).

2.2. The Location and Expression of MT1 in Antler Mesenchymal Cells

Data from RT-PCR, Western blotting, and immunofluorescent assay suggested that type I melatonin receptor (MT1) was present in the mesenchymal cells (Figure 2).

2.3. Construction of the Interference Fragment of MT1 Using Plasmid DNA

Three fragments, shRNA1, shRNA2, and shRNA3 of the MT1 gene were connected with the linear plasmid, RNAi-Ready pSIREN-RetroQZsGreen. There were 4.5 KB and 2.1 KB bands with Hind III digestion, proving that recombinant plasmids were constructed successfully (Figure 3A(Left)) and the sequencing results showed no mutations in the inserted sequence (Figure 3A(Right)). The RNAi recombinant plasmids transfected and expressed normally in mesenchymal cells after 48 h (Figure 3B). qRT-PCR verified that the interference efficiencies of shRNA2/3 (0.53 ± 0.213, 0.63 ± 0.221 vs. 1.38 ± 0.43, respectively, p < 0.05) were significantly higher than that of shRNA1 (1.01 ± 0.121 vs. 1.38 ± 0.430) (Figure 3C). The results from Western blotting were consistent with those of qRT-PCR, and compared with the control, MT1 protein levels were decreased significantly in shRNA2/3 (p < 0.05). Thus, shRNA2 was selected for subsequent experiments (Figure 3D).

2.4. Effects of MLT/MT1 Knock-Down on the Viability of Mesenchymal Cells

Compared with the control group, melatonin significantly improved cell viability during cell culture ((24 h) 125 ± 10.6% vs. 100 ± 8.4%, (48 h) 129 ± 10.5% vs. 102 ± 6.3%, respectively, p < 0.05). Cell viability in the shRNA group was significantly lower than in the control ((24 h) 70 ± 7.4% vs. 100 ± 8.4%, p < 0.05, (48 h) 79 ± 8.2% vs. 102 ± 6.3%, p < 0.01, (72 h) 84 ± 4.8% vs. 100 ± 5.3%, p < 0.05). Melatonin partially relieved the abnormal phenotype caused by MT1-knock down, with respect to comparing the cell viability between the shRNA and shRNA + MLT groups (Figure 4).

2.5. Effects of MT1 Knock-Down on Cell Proliferation-Related Gene Expression

The expression of cell proliferation-related genes was also detected. The results suggested that the expression of pro-proliferation genes (PCNA, cyclinD1) was significantly increased in the melatonin-treated group (2.65 ± 0.209 vs. 1.00 ± 0.039, 1.79 ± 0.079 vs. 1.00 ± 0.027, respectively. p < 0.01). Anti-proliferation genes, including p21 and p27, were down-regulated by melatonin treatment compared to the control (0.41 ± 0.048 vs. 1.00 ± 0.016; 0.30 ± 0.009 vs. 1.03 ± 0.154, respectively. p < 0.01); MT1 knock-down (shRNA group) inhibited the expression of PCNA and cyclinD1 significantly (0.57 ± 0.051 vs. 1.00 ± 0.039, p < 0.01, 0.71 ± 0.015 vs. 1.00 ± 0.027, p < 0.05), while it promoted the expression of p27 (2.21 ± 0.033 vs. 1.00 ± 0.039, p < 0.01). Lastly, the changes of PCNA, CyclinD1, and p27, caused by RNAi, were all partially relieved by melatonin (shRNA + MLT). Apoptosis-related genes (p53 and Caspase3) were also detected. Melatonin significantly decreased the expression of p53 (0.32 ± 0.020 vs. 1.01 ± 0.103, p < 0.01), while MT1 knock-down significantly promoted p53 and Caspase3 expression (1.82 ± 0.077 vs. 1.01 ± 0.103, 2.54 ± 0.369 vs. 1.00 ± 0.100, respectively. p < 0.01). The changes in p53 and Caspase3 caused by RNAi were all partially relieved by melatonin (shRNA + MLT) (Figure 5).

2.6. Effects of MT1 Knock-Down on IGF/IGF1-R Signaling

It was observed that melatonin significantly increased the expression of IGF1 and its trans-membrane receptor, IGF1R (1.77 ± 0.240 vs. 1.00 ± 0.010, 2.61 ± 0.040 vs. 1.00 ± 0.010, respectively, p < 0.01). Contrary to melatonin supplement, MT1 knock-down (shRNA group) significantly inhibited the expression of IGF1 and IGF1R (0.24 ± 0.040 vs. 1.00 ± 0.080, 0.49 ± 0.060 vs. 1.00 ± 0.020, respectively, p < 0.01), while the addition of melatonin in the shRNA-group relieved the expression tendency caused by RNAi (Figure 6A,B). Consistent with gene expression, the IGF-synthesis ability and cell survival rates were impaired in the shRNA group (78.67 ± 16.570 vs. 107.77 ± 7.060 ng/mL, p < 0.05, 0.81 ± 0.050 vs. 1.00 ± 0.040, respectively, p < 0.05), while melatonin supplementation also significantly abated the adverse tendency caused by RNAi (101.00 ± 6.220 vs. 107.77 ± 7.060 ng/mL, 0.97 ± 0.050 vs. 1.00 ± 0.040, respectively) (Figure 6C,D).

3. Discussion

Mesenchymal cells were located in the breeding area of antlers. During antler regeneration, the periosteal stem cells constantly differentiate to form mesenchymal cells, and then transform into cartilage cells, which promote antler growth [33,34]. Thus, the optimum metabolic conditions of mesenchymal cells sustained the rapid growth of the deer antler [3,35,36]. It is important to evaluate the regulatory mechanisms of mesenchymal cell proliferation and new measures improving antler production that may originate from them.
Melatonin, a critical hormone mainly secreted by the pineal gland, plays a key role in maintaining redox balance and biological rhythm control. It is believed that melatonin performs its functions via two pathways: Direct ROS (Reactive oxygen species)-scavenging action and a receptor-dependent (MT1, MT2) method [37,38,39]. An increasing number of studies have found that, except for the pineal gland, other organs also have the capability of melatonin synthesis, and constitute the paracrine/autocrine signaling loop in order to participate in the regulation of local metabolism [40,41]. For example, melatonin works as a local signal in the ovary to ameliorate mouse oocyte quality and participate in the regulation of luteinization [22,24]. The regeneration of antler is a periodic event. During antler regeneration, the concentration of melatonin in serum shows changes regularly, which suggests that melatonin may be involved in this process [42]. In the current research, we studied the effects of melatonin signals on mesenchymal cell proliferation with a cell model, and then analyzed the feasible mechanisms.
In this study, we first found that exogenous melatonin (400–2000 pg/mL) significantly promoted mesenchymal cell proliferation in vitro (Figure 1), which is consistent with previous reports that melatonin promotes granulosa cell and stem cell proliferation by ameliorating mitochondrial function, and also decreased ROS production and inhibited cell apoptosis [43,44,45]. However, the mechanisms by which melatonin promotes mesenchymal cell proliferation may be distinctive, as the MT1 receptor was detected in mesenchymal cells (Figure 2). Thus, we speculated that the action of melatonin in promoting mesenchymal proliferation was mediated by MT1. In order to verify this hypothesis, the optimal interference plasmid of MT1 was constructed and selected to knock down MT1 (Figure 3). Expectedly, MT1 knock-down significantly inhibited cell proliferation. Although melatonin supplementation rescued this negative action of MT1 knock-down, the beneficial effect of melatonin was crippled when compared with the melatonin-treated group (Figure 4). These data accurately confirmed that the MT1 receptor mediated the positive effects of melatonin on mesenchymal cell proliferation. Subsequently, the effects of MLT/MT1 signaling on proliferation-associated gene expression was studied; excessive activation of MLT/MT1 signaling using exogenous melatonin promoted the expression of pro-proliferation genes (PCNA, cyclinD1), and the expression of cyclin-dependent kinase inhibitor (p21, p27) and apoptosis-related genes (p53, Caspase3) were both down-regulated. The expression of these genes displayed the opposite pattern as MLT/MT1 attenuated using RNAi (Figure 5). These data suggested that the variation of proliferation-associated and apoptosis-related gene expression may contribute to increased proliferation of mesenchymal cells, stimulated by MLT/MT1 signaling.
The level of variation of insulin growth factor I (IGF1) was consistent with the growth and degradation of antler. The leading role of IGF1 in antler regeneration has been extensively validated, and it is believed that proliferation-related genes (cyclinD1, PCNA, p21, and p27, etc.) are the crucial target genes of IGF1/IGF1-R signaling, which contributes to antler regeneration [46,47]. Early studies indicated that a synergy may exist between IGF1 and melatonin signals [30]; nevertheless, thus far, no immediate evidence supports this. In this research, we investigated the relationship between MLT/MT1 and IGF1/IGF1-R during mesenchymal cell proliferation. Convincingly, the results suggested that MLT/MT1 signaling improved the expression of IGF1 and IGF1-R; meanwhile, MT1 knock-down significantly decreased the level of IGF1 (Figure 5A–C). Moreover, IGF rescued the negative effect of MT1 knock-down on mesenchymal cell proliferation (Figure 5D). These data adequately verified that IGF1/IGF1-R signaling worked as the downstream signaling of MLT/MT1 to regulate antler mesenchymal cell proliferation.

4. Materials and Methods

4.1. Sample Collection and Culture of Mesenchymal Cells

Deer antler samples were taken by the sika deer company of Jinsanxin (Wuhan, China). Interstitial tissue was cut up in 1× PBS, centrifuged at 800 rpm for 5 min and this was repeated three times; using 0.2% collagenase II (Sigma Aldrich, St. Louis, MO, USA) digestion for 30 min. Mesenchymal cells were obtained from antler of sika deer. Mesenchymal cells were grown in a culture dish in DMEM/High GLUCOSE (Hyclone, GE Healthcare, Issaquah, WA, USA) medium supplemented with 10% fetal bovine serum (FBS, Gibco BRL, Gaithersburg, MD, USA), 60 mg/mL penicillin, and 50 mg/mL streptomycin. All cultures were maintained at 37 °C in a humidified atmosphere of 5% CO2.

4.2. RNAi Plasmid Restructuring of MT1

RNAi-Ready pSIREN-RetroQZsGreen was stored by the College of Animal Science and Technology, Key Laboratory of Agricultural Animal Genetics, Breeding and Reproduction, Ministry of Education, Huazhong Agricultural University. The mRNA sequence of MT1 (ACCESSION: JN038179) was used for the target sequence of RNAi. Oligonucleotide sequences for the generation of siRNAs used in this study were designed using the Ambion siRNA Target Finder at the Ambion Inc. web (www.ambion.com/techlib/misc/siRNA_finder.html), sequence synthesis was conducted by Shanghai Sangon Limited (Shanghai, China). The three interference sequences were named shRNA1, shRNA2, and shRNA3 (Table 1). For transient transfection, mesenchymal cells were washed with 1× PBS, transfections were carried out using a Lipofectamine LTX kit (Invitrogen, Eugene, OR, USA) according to the manufacturer’s directions. Desired plasmids were diluted in Opti-MEM medium (Lifetechnology, Waltham, MA, USA), incubated for 5 min and later mixed with LTX for 30 min. Mesenchymal cells were collected for protein extraction or other analyses after transfection.

4.3. Western Blot Assay

Plasmid transfection was washed rapidly with ice-cold 1× PBS after 72 h, and later placed into a centrifugation tube containing 100 μL of ice-cold RIPA buffer, for 30 min. Then, lysates were centrifuged at 12,000 rpm for 5 min, and the supernatant was obtained and stored at −20 °C. Total protein was separated on 10% polyacrylamide gel, and then transferred to a 0.45-μm PVDF membrane. The membrane was placed in 5% nonfat dry milk in Tris Buffered Saline Tween (1× TBST) at room temperature for 1 h, and then incubated with goat polyclone anti-MT1 (Santa Cruz, CA, USA, 1:2000 for WB and 1:100 for IF), antibody or mouse monoclonal anti-β-actin antibody (1:5000, Biodragon Immunotechnologies, Beijing, China) diluted in blocking buffer at 4 °C overnight. After incubation with the primary antibodies, membranes were washed three times with TBST solution, and then incubated with HRP-conjugated rabbit anti-goat IgG antibody (1:2000, Boster Biological Technology, Co. Ltd., Beijing, China) or HRP-conjugated goat anti-mouse IgG antibody at room temperature for 2 h. After washing three times with TBST solution, the membranes were incubated with the ECL chemiluminescence reagent for 5 min, and later exposed to X-ray film for the observation of protein bands. Band intensities were measured with Gel-Pro analyzer 4.0 (Media Cybernetics, Rockville, MD, USA).

4.4. Cell Proliferation Test

The experiment was divided into a control group and experimental groups (added with 400, 800, 1200, 1600, and 2000 pg/mL melatonin). Plasmid transfection was performed after 24 h, 48 h, and 72 h; the cell proliferation rate was detected by MTT (Dojindo, Kyushu, Japan). Each group added with 50 μL MTT and cultured for 4 h, then 150 μL DMSO (Sigma Aldrich, St. Louis, MO, USA) was added in each group and incubated for 10 min in a shaking bed at 37 °C, using enzyme standard instruments to detect the λ = 550 nm absorbance values.

4.5. Immunofluorescence Assay

For the detection of the sub-cellular localization pattern of MT1, indirect immunofluorescence staining was conducted after transfection. Cells were cultured in a confluent monolayer on glass cover slips and transfected with plasmids. At 48 h after transfection, cells were washed three times with PBS and fixed in 4% paraformaldehyde for 30 min. After washing three times with PBS, cells were permeabilized for 20 min with 0.5% Triton-100 at room temperature, and then blocked in 5% bovine serum albumin. Then, the cells were incubated with anti-MT1 primary antibody overnight at 4 °C. The next day, cells were washed three times with PBS, and incubated with FITC-conjugated secondary antibody (1:100, Boster Biological Technology, Beijing, China) in the dark for 1 h. The nuclei of the cells were stained with 10 μg/mL 4,6-diamidino-2-phenylindole (DAPI, Servicebio, Wuhan, China) for 5 min. After that, a cover slip was mounted and analyzed under a Nikon TE2000-U Fluorescence microscope (Nikon, Tokyo, Japan).

4.6. Real-Time PCR Analysis

Real-time quantitative PCRs were run using a QuantiFast SYBR Green PCR Kit on a BIORAD CFX Manager Machine (Bio-Rad, Hercules, CA, USA). The MT1, IGF1, IGF1-R, Cyclin D1, PCNA, P21, P27 and P53, as well as the β-actin primers (shown in Table 2) were designed using Primer Premier 5 software and synthesized (TSINGKE Biological Technology Company, Wuhan, China); samples were prepared according to the manufacturer’s instructions. The total reaction volume of 10 μL contained 5 μL Master Mix, 1 μL primers, 1 μL diluted cDNA and 3 μL ddH2O. The samples were then centrifuged at 1000× g at 4 °C for 1 min. All cDNA samples were amplified under the following conditions: 95 °C for 1 min, 40 cycles at 95 °C for 10 s, and 55 °C for 30 s. The data were subsequently quantified according to the comparative cycle threshold method, and expression levels were presented as 2−ΔCT normalized to the β-actin housekeeping gene.

4.7. Enzyme-Linked Immunosorbent Assay (ELISA) Assay

IGF1 was detected using an indirect ELISA method. The 96-well immunoplates were coated with 100 ng of IGF1 (PeproTech, Rocky Hill, NJ, USA) diluted in bicarbonate buffer (pH 9.6) overnight at 4 °C. Following blocking with 5% (w/v) dry skimmed milk in PBS (pH 7.2) for 1 h at 37 °C, 1:50 dilution of plasma samples in 0.05% Tween-20 in PBS (PBST) were added to the wells and the plates were incubated for 1 h at 37 °C. Each sample was tested in triplicate; positive and negative controls were also used. Bound antibody was detected by the addition of 100 μL of HRP-labeled goat anti-rat IgG antibodies in PBST and incubated for 1 h at 37 °C. To develop the ELISA results, 10 mg of tetramethylbenzidine (TMB tablets, Sigma-Aldrich, St. Louis, MO, USA) were dissolved in absolute ethanol that was mixed with phosphate–citrate buffer (pH 5.0) using H2O2 as a substrate, and then incubated for 10 min at 37 °C. Reactions were terminated with 2 mol/L H2SO4 and the resulting optical density (OD) was measured at 450 nm in a plate reader (Thermo Electron Corporation, PerkinElmer, Waltham, MA, USA).

4.8. Data Analysis and Statistics

All experiments were repeated at least three times independently. Bio-Rad IQ5 software (Bio-Rad Laboratories, Hercules, CA, USA) and Microsoft Office Excel were used to analyze RT-PCR, using the 2−ΔΔCT method to calculate mRNA expression. The data were represented as mean ± SEM and analyzed using SPSS 19.0 software (SPSS, Chicago, IL, USA). If differences were found after One-Way ANOVA, significance was measured by using Tukey’s post hoc test. A value of p < 0.05 was considered significantly different and extremely significant when p < 0.01.

5. Conclusions

In conclusion, the current experiments suggested that melatonin regulates antler mesenchymal cell proliferation via the MT1 receptor. Mechanism research verified that MLT/MT1 signaling enhanced IGF1/IGF1-R signaling by increasing both IGF1 and IGF1-R expression. This study supplies definite proof, using a cell model, to support the view that melatonin promotes antler regeneration by activating IGF1/IGF1-R. This study provides an important theoretical basis to improve antler production using melatonin.

Acknowledgments

This work was supported by the National Key Research and Development Program (2017YFD0501701), the National Natural Science Foundation of China (31701301), and the Natural Science Foundation of Hubei province of China (2015CFB651).

Author Contributions

Lijun Huo, Jiajun Xiong, Liguo Yang, and Guoshi Liu conceived of and designed the experiments and revised the manuscript; Feifei Yang, Changjiu He, Xuyang Sun, Jing Wang, and Can Luo performed the experiments; Feifei Yang, Changjiu He, and Xuyang Sun analyzed the data; and Feifei Yang and Changjiu He wrote the paper.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Price, J.; Allen, S. Exploring the mechanisms regulating regeneration of deer antlers. Proc. R. Soc. Lond. B 2004, 359, 809–822. [Google Scholar] [CrossRef] [PubMed]
  2. Kierdorf, U.; Kierdorf, H.; Schultz, M.; Rolf, H.J. Histological structure of antlers in castrated male fallow deer (Dama dama). Anat. Rec. A 2004, 281A, 1352–1362. [Google Scholar] [CrossRef] [PubMed]
  3. Li, C.; Zhao, H.; Liu, Z.; Mcmahon, C. Deer antler—A novel model for studying organ regeneration in mammals. Int. J. Biochem. Cell Biol. 2014, 56, 111–122. [Google Scholar] [CrossRef] [PubMed]
  4. Kierdorf, U.; Kierdorf, H.; Szuwart, T. Deer antler regeneration: Cells, concepts, and controversies. J. Morphol. 2007, 268, 726–738. [Google Scholar] [CrossRef] [PubMed]
  5. Rolf, H.J.; Kierdorf, U.; Kierdorf, H.; Schulz, J.; Seymour, N.; Schliephake, H.; Napp, J.; Niebert, S.; Wölfel, H.; Wiese, K.G. Localization and characterization of STRO-1 cells in the deer pedicle and regenerating antler. PLoS ONE 2008, 3, e2064. [Google Scholar] [CrossRef] [PubMed]
  6. Molnár, A.; Gyurján, I.; Korpos, E.; Borsy, A.; Stéger, V.; Buzás, Z.; Kiss, I.; Zomborszky, Z.; Papp, P.; Deák, F.; et al. Identification of differentially expressed genes in the developing antler of red deer Cervus elaphus. Mol. Genet. Genom. 2007, 277, 237–248. [Google Scholar] [CrossRef] [PubMed]
  7. Kierdorf, U.; Kierdorf, H. Deer antlers-a model of mammalian appendage regeneration: An extensive review. Gerontology 2011, 57, 53–65. [Google Scholar] [CrossRef] [PubMed]
  8. Suttie, J.M.; Gluckman, P.D.; Butler, J.H.; Fennessy, P.F.; Corson, I.D.; Laas, F.J. Insulin-like growth factor 1 (IGF-1) antler-stimulating hormone. Endocrinology 1985, 116, 846–848. [Google Scholar] [CrossRef] [PubMed]
  9. Price, J.S.; Oyajobi, B.O.; Oreffo, R.O.C.; Russel, R.G. Cells cultured from the growing tip of red deer antler express alkaline phosphatase and proliferate in response to insulin-like growth factor-I. J. Endocrinol. 1994, 143, R9–R16. [Google Scholar] [CrossRef] [PubMed]
  10. Park, J.; Jeon, B.; Kang, S.; Oh, M.; Kim, M.; Jang, S.; Park, P.; Kim, S.; Moon, S. Study on the changes in enzyme and insulin-like growth factor-1 concentrations in blood serum and growth characteristics of velvet antler during the antler growth period in sika deer (Cervus nippon). Asian Austral. J. Anim. 2015, 28, 1303–1308. [Google Scholar] [CrossRef] [PubMed]
  11. Sadighi, M.; Haines, S.R.; Skottner, A.; Harris, A.J.; Suttie, J.M. Effects of insulin-like growth factor-I (IGF-I) and IGF-II on the growth of antler cells in vitro. J. Endocrinol. 1994, 143, 461–469. [Google Scholar] [CrossRef] [PubMed]
  12. Gu, L.; Mo, E.; Yang, Z.; Zhu, X.; Fang, Z.; Sun, B.; Wang, C.; Bao, J.; Sung, C. Expression and localization of insulin-like growth factor-I in four parts of the red deer antler. Growth Factors 2007, 25, 264–279. [Google Scholar] [CrossRef] [PubMed]
  13. Jarzynka, M.J.; Passey, D.K.; Johnson, D.A.; Konduru, N.V.; Fitz, N.F.; Radio, N.M.; Rasenick, M.; Benloucif, S.; Melan, M.A.; Witt-Enderby, P.A. Microtubules modulate melatonin receptors involved in phase-shifting circadian activity rhythms: In vitro and in vivo evidence. J. Pineal Res. 2009, 46, 161–171. [Google Scholar] [CrossRef] [PubMed]
  14. Cardinali, D.P.; Srinivasan, V.; Brzezinski, A.; Brown, G.M. Melatonin and its analogs in insomnia and depression. J. Pineal Res. 2012, 52, 365–375. [Google Scholar] [CrossRef] [PubMed]
  15. Rodriguez-Garcia, A.; Mayo, J.C.; Hevia, D.; Quiros-Gonzalez, I.; Navarro, M.; Sainz, R.M. Phenotypic changes caused by melatonin increased sensitivity of prostate cancer cells to cytokine-induced apoptosis. J. Pineal Res. 2013, 54, 33–45. [Google Scholar] [CrossRef] [PubMed]
  16. Gurer-Orhan, H.; Suzen, S. Melatonin, its metabolites and its synthetic analogs as multi-faceted compounds: Antioxidant, prooxidant and inhibitor of bioactivation reactions. Curr. Med. Chem. 2015, 22, 490–499. [Google Scholar] [CrossRef] [PubMed]
  17. Marková, M.; Adámeková, E.; Kubatka, P.; Bojková, B.; Ahlersová, E.; Ahlers, I. Effect of prolonged melatonin application on metabolic parameters and organ weights in young male and female Sprague-Dawley rats. Acta Vet. Brno 2003, 72, 163–173. [Google Scholar] [CrossRef]
  18. De Berardis, D.; Marini, S.; Fornaro, M.; Srinivasan, V.; Iasevoli, F.; Tomasetti, C.; Valchera, A.; Perna, G.; Quera-Salva, M.A.; Martinotti, G.; et al. The melatonergic system in mood and anxiety disorders and the role of agomelatine: Implications for clinical practice. Int. J. Mol. Sci. 2013, 14, 12458–12483. [Google Scholar] [CrossRef] [PubMed]
  19. De Berardis, D.; Fornaro, M.; Serroni, N.; Campanella, D.; Rapini, G.; Olivieri, L.; Srinivasan, V.; Iasevoli, F.; Tomasetti, C.; de Bartolomeis, A.; et al. Agomelatine beyond borders: Current evidences of its efficacy in disorders other than major depression. Int. J. Mol. Sci. 2013, 16, 1111–1130. [Google Scholar] [CrossRef] [PubMed]
  20. Kubatka, P.; Bojková, B.; Mciková-Kalická, K.; Mníchová-Chamilová, M.; Adámeková, E.; Ahlers, I.; Ahlersová, E.; Cermáková, M. Effects of tamoxifen and melatonin on mammary gland cancer induced by N-methyl-N-nitrosourea and by 7, 12-dimethylbenz (a) anthracene, respectively, in female Sprague-Dawley rats. Folia Biol. (Praha) 2001, 47, 5–10. [Google Scholar] [PubMed]
  21. Mayo, J.C.; Sainz, R.M.; González Menéndez, P.; Cepas, V.; Tan, D.X.; Reiter, R.J. Melatonin and sirtuins: A “not-so unexpected” relationship. J. Pineal Res. 2017, 62. [Google Scholar] [CrossRef] [PubMed]
  22. He, C.; Wang, J.; Zhang, Z.; Yang, M.; Li, Y.; Tian, X.; Ma, T.; Tao, J.; Zhu, K.; Song, Y.; et al. Mitochondria synthesize melatonin to ameliorate its function and improve mice oocyte’s quality under in vitro conditions. Int. J. Mol. Sci. 2016, 17, 939. [Google Scholar] [CrossRef] [PubMed]
  23. He, C.; Wang, J.; Li, Y.; Zhu, K.; Xu, Z.; Song, Y.; Song, Y.; Liu, G. Melatonin-related genes expressed in the mouse uterus during early gestation promote embryo implantation. J. Pineal Res. 2015, 58, 300–309. [Google Scholar] [CrossRef] [PubMed]
  24. He, C.; Ma, T.; Shi, J.; Zhang, Z.; Wang, J.; Zhu, K.; Li, Y.; Yang, M.; Song, Y.; Liu, G. Melatonin and its receptor MT1 are involved in the downstream reaction to luteinizing hormone and participate in the regulation of luteinization in different species. J. Pineal Res. 2016, 61, 279–290. [Google Scholar] [CrossRef] [PubMed]
  25. De Berardis, D.; Fornaro, M.; Orsolini, L.; Iasevoli, F.; Tomasetti, C.; de Bartolomeis, A.; Serroni, N.; de Lauretis, I.; Girinelli, G.; Mazza, M.; et al. Effect of agomelatine treatment on C-reactive protein levels in patients with major depressive disorder: An exploratory study in “real-world,” everyday clinical practice. CNS Spectr. 2017, 22, 342–347. [Google Scholar] [CrossRef] [PubMed]
  26. Martinotti, G.; Pettorruso, M.; De Berardis, D.; Varasano, P.A.; Lucidi Pressanti, G.; de Remigis, V.; Valchera, A.; Ricci, V.; di Nicola, M.; Janiri, L.; et al. Agomelatine increases BDNF serum levels in depressed patients in correlation with the improvement of depressive symptoms. Int. J. Neuropsychopharmacol. 2016, 19. [Google Scholar] [CrossRef] [PubMed]
  27. Wilson, P.R.; Walker, I.H.; Bond, D.B.; Middleberg, A.; Staple, L.D. Field evaluation of melatonin implants to advance the breeding season in l-year-old farmed red deer hinds. N. Z. Vet. J. 1991, 39, 23–28. [Google Scholar] [CrossRef] [PubMed]
  28. Bubenik, G.A.; Smith, P.S.; Schams, D. The effect of orally administered melatonin on the seasonality of deer pelage exchange, antler development, LH, FSH, prolactin, testosterone, T3, T4, cortisol and alkaline phosphatase. J. Pineal Res. 1986, 3, 331–349. [Google Scholar] [CrossRef] [PubMed]
  29. Webster, J.R.; Suttie, J.M.; Corson, I.D. Effects of melatonin implants on reproductive seasonality of male red deer (Cervus elaphus). J. Reprod. Fertil. 1991, 92, 1–11. [Google Scholar] [CrossRef] [PubMed]
  30. Suttie, J.M.; Breier, B.H.; Gluckman, P.D.; Littlejohn, R.P.; Webster, J.R. Effects of melatonin implants on insulin-like growth factor 1 in male red deer (Cervus elaphus). Gen. Comp. Endocrinol. 1992, 87, 111–119. [Google Scholar] [CrossRef]
  31. Yang, F.F.; Zhang, P.; Huo, L.J.; Riaz, H.; Yang, L.G.; Zhang, S.J.; Xiong, J.J. The association of single nucleotide polymorphism in the IGF1, IGF2 and IGF1R with antler yield in Sika deer. Pak. Vet. J. 2014, 34, 469–473. [Google Scholar]
  32. Yang, F.F.; Huo, L.J.; Yang, L.G.; Riaz, H.; Xiong, L.R.; Chen, J.G.; Zhang, S.J.; Xiong, J.J. Association between melatonin receptor 1A (MTNR1A) gene single-nucleotide polymorphisms and the velvet antler yield of Sika deer. Mol. Biol. Rep. 2014, 41, 1901–1906. [Google Scholar] [CrossRef] [PubMed]
  33. Gyurján, I.; Molnár, A.; Borsy, A.; Stéger, V.; Hackler, L.; Zomborszky, Z.; Papp, P.; Duda, E.; Deák, F.; Lakatos, P.; et al. Gene expression dynamics in deer antler: Mesenchymal differentiation toward chondrogenesis. Mol. Genet. Genom. 2007, 277, 221–235. [Google Scholar] [CrossRef] [PubMed]
  34. Li, C.; Yang, F.; Haines, S.; Zhao, H.; Wang, W.; Xing, X.; Sun, H.; Chu, W.; Lu, X.; Liu, L.; et al. Stem cells responsible for deer antler regeneration are unable to recapitulate the process of first antler development—Revealed through intradermal and subcutaneous tissue transplantation. J. Exp. Zool. Part B 2010, 314B, 552–570. [Google Scholar] [CrossRef] [PubMed]
  35. Cegielski, M.; Izykowska, I.; Podhorska-Okolow, M.; Gworys, B.; Zabel, M.; Dziegiel, P. Histological studies of growing and mature antlers of red deer stags (Cervus elaphus). Anat. Histol. Embryol. 2009, 38, 184–188. [Google Scholar] [CrossRef] [PubMed]
  36. Pita-Thomas, W.; Barroso-García, G.; Moral, V.; Hackett, A.R.; Cavalli, V.; Nieto-Diaz, M. Identification of axon growth promoters in the secretome of the deer antler velvet. Neuroscience 2016, 340, 333–344. [Google Scholar] [CrossRef] [PubMed]
  37. Manchester, L.C.; Coto Montes, A.; Boga, J.A.; Andersen, L.P.H.; Zhou, Z.; Galano, A.; Vriend, J.; Tan, D.X.; Reiter, R.J. Melatonin: An ancient molecule that makes oxygen metabolically tolerable. J. Pineal Res. 2015, 59, 403–419. [Google Scholar] [CrossRef] [PubMed]
  38. Reiter, R.J.; Tan, D.X.; Maldonado, M.D. Melatonin as an antioxidant: Physiology versus pharmacology. J. Pineal Res. 2005, 39, 215–216. [Google Scholar] [CrossRef] [PubMed]
  39. Emet, M.; Ozcan, H.; Ozel, L.; Yayla, M.; Halici, Z.; Hacimuftuoglu, A. A review of melatonin, its receptors and drugs. Eur. J. Med. 2016, 48, 135–141. [Google Scholar] [CrossRef] [PubMed]
  40. Reiter, R.J.; Rosales-Corral, S.A.; Manchester, L.C.; Liu, X.; Tan, D.X. Melatonin in the biliary tract and liver: Health implications. Curr. Pharm. Design 2014, 20, 4788–4801. [Google Scholar] [CrossRef]
  41. Simko, F.; Baka, T.; Paulis, L.; Reiter, R.J. Elevated heart rate and nondipping heart rate as potential targets for melatonin: A review. J. Pineal Res. 2016, 61, 127–137. [Google Scholar] [CrossRef] [PubMed]
  42. Bubenik, G.A.; Smith, P.S. Circadian and circannual rhythms of melatonin in plasma of male white-tailed deer and the effect of oral administration of melatonin. J. Exp. Zool. Part A 1987, 241, 81–89. [Google Scholar] [CrossRef] [PubMed]
  43. Lee, M.S.; Yin, T.C.; Sung, P.H.; Chiang, J.Y.; Sun, C.K.; Yip, H.K. Melatonin enhances survival and preserves functional integrity of stem cells: A review. J. Pineal Res. 2017. [Google Scholar] [CrossRef] [PubMed]
  44. Tanabe, M.; Tamura, H.; Taketani, T.; Okada, M.; Lee, L.; Tamura, I.; Sugino, N. Melatonin protects the integrity of granulosa cells by reducing oxidative stress in nuclei, mitochondria, and plasma membranes in mice. J. Reprod. Dev. 2015, 61, 35–41. [Google Scholar] [CrossRef] [PubMed]
  45. Song, C.; Peng, W.; Yin, S.; Zhao, J.; Fu, B.; Zhang, J.; Zhang, Y. Melatonin improves age-induced fertility decline and attenuates ovarian mitochondrial oxidative stress in mice. Sci. Rep. 2016, 6, 35165. [Google Scholar] [CrossRef] [PubMed]
  46. Yang, Z.Q.; Zhang, H.L.; Duan, C.; Geng, C.; Wang, S.; Yu, K.; Yue, Z.P.; Guo, B. IGF1 regulates RUNX1 expression via IRS1/2: Implications for antler chondrocyte differentiation. Cell Cycle 2017, 16, 522–532. [Google Scholar] [CrossRef] [PubMed]
  47. Hu, W.; Li, T.; Wu, L.; Li, M.; Meng, X. Identification of microRNA-18a as a novel regulator of the insulin-like growth factor-1 in the proliferation and regeneration of deer antler. Biotechnol. Lett. 2014, 36, 703–710. [Google Scholar] [CrossRef] [PubMed]
  • Sample Availability: Samples of the compounds are not available from the authors.
Figure 1. Effects of melatonin on cell proliferation. (A) Cell identification using toluidine blue-staining, Scale bar = 100 μm; (B) cell proliferation detection using MTT. ** represents significant differences, p < 0.01. The different superscript letters (a–b) represent significant differences of these columns (p < 0.05).
Figure 1. Effects of melatonin on cell proliferation. (A) Cell identification using toluidine blue-staining, Scale bar = 100 μm; (B) cell proliferation detection using MTT. ** represents significant differences, p < 0.01. The different superscript letters (a–b) represent significant differences of these columns (p < 0.05).
Molecules 22 01793 g001
Figure 2. The expression of MT1 in mesenchymal cells. (A) Assayed using RT-PCR; objective strap size: 476 bp; (B) Assayed using Western blotting; objective strap size: 45 kDa; (C) Assayed using immunofluorescence; red indicates MT1 staining, blue indicated nucleus, stained with DAPI, Scale bar = 100 μm.
Figure 2. The expression of MT1 in mesenchymal cells. (A) Assayed using RT-PCR; objective strap size: 476 bp; (B) Assayed using Western blotting; objective strap size: 45 kDa; (C) Assayed using immunofluorescence; red indicates MT1 staining, blue indicated nucleus, stained with DAPI, Scale bar = 100 μm.
Molecules 22 01793 g002
Figure 3. Efficiency identification of recombinant interference plasmids of MT1. (A) Enzyme digestion (left) and sequencing identification (right); (B) detection of transfection efficiency; (left) bright-field, (right) fluorescent light, Scale bar = 100 μm; (C) comparison of interference efficiency using qRT-PCR; (D) comparison of interference efficiency using Western blotting. * represents significant differences, p < 0.05, ** represents significant differences, p < 0.01.
Figure 3. Efficiency identification of recombinant interference plasmids of MT1. (A) Enzyme digestion (left) and sequencing identification (right); (B) detection of transfection efficiency; (left) bright-field, (right) fluorescent light, Scale bar = 100 μm; (C) comparison of interference efficiency using qRT-PCR; (D) comparison of interference efficiency using Western blotting. * represents significant differences, p < 0.05, ** represents significant differences, p < 0.01.
Molecules 22 01793 g003
Figure 4. Effects of MLT/MT1 knock-down on the viability of mesenchymal cells. The different superscript letters (a–c) represent significant differences of these columns (p < 0.05).
Figure 4. Effects of MLT/MT1 knock-down on the viability of mesenchymal cells. The different superscript letters (a–c) represent significant differences of these columns (p < 0.05).
Molecules 22 01793 g004
Figure 5. Effect of MT1 knock-down on genes expression. The different superscript letters (a–c) represent significant differences of these columns (p < 0.05).
Figure 5. Effect of MT1 knock-down on genes expression. The different superscript letters (a–c) represent significant differences of these columns (p < 0.05).
Molecules 22 01793 g005
Figure 6. Effect of MT1 knock-down on IGF/IGF1-R signaling. (A) The expression of IGF1; (B) the expression of IGF1-R; (C) IGF level in culture medium; (D) the effect on the cell survival rate. Different superscript letters (a–c) represent significant differences of these columns (p < 0.05).
Figure 6. Effect of MT1 knock-down on IGF/IGF1-R signaling. (A) The expression of IGF1; (B) the expression of IGF1-R; (C) IGF level in culture medium; (D) the effect on the cell survival rate. Different superscript letters (a–c) represent significant differences of these columns (p < 0.05).
Molecules 22 01793 g006
Table 1. shRNA sequence of MT1.
Table 1. shRNA sequence of MT1.
NameSense/AntisenseSequence Sense
shRNA1Sense5′-GATCCGGTCAATAGAGAATTAACAGTTCAAGAG ACTGTTAATTCTCTATTGACCTTTTTTAAGCTTG-3′
Antisense5′-AATTCAAGCTTAAAAAAGGTCAATAGAGAATTA ACAGTCTCTTGAACTGTTAATTCTCTATTGACCG-3′
shRNA2Sense5′-GATCCGCGTAGCAGATAGAATTAAATTCAAGAGA TTTAATTCTATCTGCTACGCTTTTTTAAGCTTG-3′
Antisense5′-AATTCAAGCTTAAAAAAGCGTAGCAGATAGAAT TAAATCTCTTGAATTTAATTCTATCTGCTACGCG-3′
shRNA3Sense5′-GATCCGGGATCTATTCCTGCACCTTCATTCAAGAGA TGAAGGTGCAGGAATAGATCCCTTTTTTAAGCTTG-3′
Antisense5′-AATTCAAGCTTAAAAAAGGGATCTATTCCTGCACC TTCATCTCTTGAATGAAGGTGCAGGAATAGATCCCG-3′
Table 2. Primers used in this study for real-time PCR.
Table 2. Primers used in this study for real-time PCR.
GenePrimer Sequence (5′-3′)Tm (°C)Product Size (bp)
β-actinF: TGACCCTTAAGTACCCCATCGA6085 bp
R: TTGTAGAAGGTGTGGTGCCAGAT
MT1F: TGGCTGTTTGTGGCCAGTTA60158 bp
R: ACGTGATTGGAGCTATCCGC
IGF1F: TGTGATTTCTTGAAGCAGGTGA6096 bp
R: CGTGGCAGAGCTGGTGAAG
IGF-1RF: GCACCATCTTCAAAGGCAATC6095 bp
R: GAGACCAAGGCGTGGGAGT
Cyclin D1F: GCGCAGACCTTCGTTGCCCT60123 bp
R: GCCGTTGGCGCTTCCCAGAT
PCNAF: CCTTGGTGCAGCTAACCCTT6094 bp
R: TTGGACATGCTGGTGAGGTT
P21F: GACCACTTGGACCTGTCGCT60183 bp
R: GGGTTAGGGCTTCCTCTTGG
P27F: AGTGTCTAACGGGAGTCCGA60213 bp
R: CACTCGTACTTGCCCTCCAG
P53F: GAAGACCTACCCTGGCAATTAC60103 bp
R: AGAACAGCTTGTTAAGGGAAGG
Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top